AxoGen Inc
NASDAQ:AXGN
Net Margin
AxoGen Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
AxoGen Inc
NASDAQ:AXGN
|
466.5m USD |
-4%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
237.9B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
187B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.3B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
149.9B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.2B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.7B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.8B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
277.7B CNY |
31%
|
AxoGen Inc
Glance View
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on AxoGen Inc's most recent financial statements, the company has Net Margin of -3.7%.
You don't have any saved screeners yet